Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Posternak

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Psychiatry|June 18, 2005
Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective studyMichael A Posternak, Mark Zimmerman
The American Journal of Psychiatry|July 5, 2005
Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trialMark Zimmerman, Iwona Chelminski, Michael A Posternak
Essential Psychopharmacology|December 23, 2004
Generalizability of antidepressant efficacy trialsMark Zimmerman, Michael A Posternak, Iwona Chelminski
The Journal of Nervous and Mental Disease|February 11, 2004
Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples includedMark Zimmerman, Iwona Chelminski, Michael A Posternak
The Journal of Clinical Psychiatry|March 9, 2004
Defining remission on the Montgomery-Asberg depression rating scaleMark Zimmerman, Michael A Posternak, Iwona Chelminski
Journal of Clinical Psychopharmacology|November 28, 2002
Symptom severity and exclusion from antidepressant efficacy trialsMark Zimmerman, Michael A Posternak, Iwona Chelminski
Journal of Psychiatric Research|October 2, 2004
Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depressionMark Zimmerman, Michael A Posternak, Iwona Chelminski
International Clinical Psychopharmacology|June 18, 2004
Implications of using different cut-offs on symptom severity scales to define remission from depressionMark Zimmerman, Michael A Posternak, Iwona Chelminski
Comprehensive Psychiatry|February 13, 2007
Heterogeneity among depressed outpatients considered to be in remissionMark Zimmerman, Michael A Posternak, Iwona Chelminski
The Journal of Nervous and Mental Disease|February 25, 2005
Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?Mark Zimmerman, Michael A Posternak, Iwona Chelminski
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Psychiatry|June 18, 2005
Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective studyMichael A Posternak, Mark Zimmerman
The American Journal of Psychiatry|July 5, 2005
Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trialMark Zimmerman, Iwona Chelminski, Michael A Posternak
Essential Psychopharmacology|December 23, 2004
Generalizability of antidepressant efficacy trialsMark Zimmerman, Michael A Posternak, Iwona Chelminski
The Journal of Nervous and Mental Disease|February 11, 2004
Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples includedMark Zimmerman, Iwona Chelminski, Michael A Posternak
The Journal of Clinical Psychiatry|March 9, 2004
Defining remission on the Montgomery-Asberg depression rating scaleMark Zimmerman, Michael A Posternak, Iwona Chelminski
Journal of Clinical Psychopharmacology|November 28, 2002
Symptom severity and exclusion from antidepressant efficacy trialsMark Zimmerman, Michael A Posternak, Iwona Chelminski
Journal of Psychiatric Research|October 2, 2004
Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depressionMark Zimmerman, Michael A Posternak, Iwona Chelminski
International Clinical Psychopharmacology|June 18, 2004
Implications of using different cut-offs on symptom severity scales to define remission from depressionMark Zimmerman, Michael A Posternak, Iwona Chelminski
Comprehensive Psychiatry|February 13, 2007
Heterogeneity among depressed outpatients considered to be in remissionMark Zimmerman, Michael A Posternak, Iwona Chelminski
The Journal of Nervous and Mental Disease|February 25, 2005
Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?Mark Zimmerman, Michael A Posternak, Iwona Chelminski
Pageof 5